相似文献
1
State of the art in tumor antigen and biomarker discovery.
Cancers (Basel). 2011 Jun 9;3(2):2554-96. doi: 10.3390/cancers3022554.
2
Towards a Systems Immunology Approach to Unravel Responses to Cancer Immunotherapy.
Front Immunol. 2020 Oct 22;11:582744. doi: 10.3389/fimmu.2020.582744. eCollection 2020.
3
Cancer Biomarkers Discovery and Validation: State of the Art, Problems and Future Perspectives.
Adv Exp Med Biol. 2015;867:9-26. doi: 10.1007/978-94-017-7215-0_2.
4
The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
Toxicol Appl Pharmacol. 2010 May 15;245(1):134-42. doi: 10.1016/j.taap.2010.02.011. Epub 2010 Feb 26.
5
Predictive biomarkers in clinical practice: State of the art and perspectives in solid tumors.
Int J Biol Markers. 2020 Feb;35(1_suppl):16-19. doi: 10.1177/1724600820904964.
6
Cancer biomarker discovery and translation: proteomics and beyond.
Expert Rev Proteomics. 2019 Feb;16(2):93-103. doi: 10.1080/14789450.2019.1559062. Epub 2018 Dec 24.
7
Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery.
Expert Rev Proteomics. 2016;13(4):395-409. doi: 10.1586/14789450.2016.1165613.
8
Novel technologies and emerging biomarkers for personalized cancer immunotherapy.
J Immunother Cancer. 2016 Jan 19;4:3. doi: 10.1186/s40425-016-0107-3. eCollection 2016.
9
Circulating protein and antibody biomarker for personalized cancer immunotherapy.
J Immunother Cancer. 2016 Aug 16;4:46. doi: 10.1186/s40425-016-0150-0. eCollection 2016.
10
Identifying biomarkers for predicting successful embryo implantation: applying single to multi-OMICs to improve reproductive outcomes.
Hum Reprod Update. 2020 Feb 28;26(2):264-301. doi: 10.1093/humupd/dmz042.
引用本文的文献
1
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer.
Front Oncol. 2024 Jul 17;14:1427802. doi: 10.3389/fonc.2024.1427802. eCollection 2024.
2
Near Infrared Photoimmunotherapy: A Review of Recent Progress and Their Target Molecules for Cancer Therapy.
Int J Mol Sci. 2023 Jan 31;24(3):2655. doi: 10.3390/ijms24032655.
3
Targeting Mutant Kirsten Rat Sarcoma Viral Oncogene Homolog in Non-Small Cell Lung Cancer: Current Difficulties, Integrative Treatments and Future Perspectives.
Front Pharmacol. 2022 Apr 20;13:875330. doi: 10.3389/fphar.2022.875330. eCollection 2022.
4
Colorectal Cancer Immunotherapy: Options and Strategies.
Front Immunol. 2020 Sep 18;11:1624. doi: 10.3389/fimmu.2020.01624. eCollection 2020.
5
Targeting Acidic Diseased Tissues by pH-Triggered Membrane-Associated Peptide Folding.
Front Bioeng Biotechnol. 2020 Apr 28;8:335. doi: 10.3389/fbioe.2020.00335. eCollection 2020.
6
Tailoring subtractive cell biopanning to identify diffuse gastric adenocarcinoma-associated antigens via human scFv antibodies.
Immunology. 2020 Jan;159(1):96-108. doi: 10.1111/imm.13129. Epub 2019 Nov 8.
7
Pentaerythritol-based lipid A bolsters the antitumor efficacy of a polyanhydride particle-based cancer vaccine.
Nanomedicine. 2019 Oct;21:102055. doi: 10.1016/j.nano.2019.102055. Epub 2019 Jul 15.
8
A comprehensive overview of mitochondrial DNA 4977-bp deletion in cancer studies.
Oncol Rev. 2019 Apr 16;13(1):409. doi: 10.4081/oncol.2019.409. eCollection 2019 Jan 14.
9
Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment.
J Exp Clin Cancer Res. 2019 Apr 15;38(1):162. doi: 10.1186/s13046-019-1153-8.
10
Protein-based nanoparticles in cancer vaccine development.
Nanomedicine. 2019 Jan;15(1):164-174. doi: 10.1016/j.nano.2018.09.004. Epub 2018 Oct 4.
本文引用的文献
1
Intra-lymph node prime-boost vaccination against Melan A and tyrosinase for the treatment of metastatic melanoma: results of a phase 1 clinical trial.
Clin Cancer Res. 2011 May 1;17(9):2987-96. doi: 10.1158/1078-0432.CCR-10-3272. Epub 2011 Mar 8.
2
Inhibition of the Nef regulatory protein of HIV-1 by a single-domain antibody.
Blood. 2011 Mar 31;117(13):3559-68. doi: 10.1182/blood-2010-07-296749. Epub 2011 Feb 3.
3
Sipuleucel-T: Prototype for development of anti-tumor vaccines.
Curr Oncol Rep. 2011 Apr;13(2):112-9. doi: 10.1007/s11912-011-0152-5.
4
HER2: biology, detection, and clinical implications.
Arch Pathol Lab Med. 2011 Jan;135(1):55-62. doi: 10.5858/2010-0454-RAR.1.
5
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.
Cancer Immunol Immunother. 2011 Feb;60(2):261-71. doi: 10.1007/s00262-010-0935-9. Epub 2010 Nov 11.
6
Biological markers in breast cancer prognosis and treatment.
J BUON. 2010 Jul-Sep;15(3):447-54.
7
Strong and oriented immobilization of single domain antibodies from crude bacterial lysates for high-throughput compatible cost-effective antibody array generation.
Mol Biosyst. 2010 Nov;6(11):2241-8. doi: 10.1039/c005279e. Epub 2010 Sep 21.
8
Strategies for cancer vaccine development.
J Biomed Biotechnol. 2010;2010. doi: 10.1155/2010/596432. Epub 2010 Jul 11.
9
Gene expression profiling in breast cancer.
Cancer Control. 2010 Jul;17(3):177-82. doi: 10.1177/107327481001700306.
10
Cancer immunotherapy.
Vet Clin North Am Small Anim Pract. 2010 May;40(3):507-18. doi: 10.1016/j.cvsm.2010.01.002.
Zotero 插件